Supergen, Inc.
55Patents
5Active
55Granted
37Portfolio score
Filing activity: Aug 26, 1994 → Apr 10, 2009 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6998391B2 | Method for treating diseases associated with abnormal kinase activity | Human Necessities | 80 | Expired |
| US7750007B2 | Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors | Human Necessities | 79 | Active |
| US6905669B2 | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase | Human Necessities | 75 | Expired |
| US6136846A | Formulation for paclitaxel | Performing Operations; Transporting | 63 | Expired |
| US5602112A | Pharmaceutical formulation | Performing Operations; Transporting | 42 | Expired |
| US6319943A | Oral formulation for paclitaxel | Performing Operations; Transporting | 37 | Expired |
| US7326712B2 | Substituted tricyclic compounds as protein kinase inhibitors | Chemistry; Metallurgy | 33 | Expired |
| US7998966B2 | Axl kinase inhibitors | Chemistry; Metallurgy | 31 | Active |
| US7060290B1 | Phosphocholine linked prodrug derivatives | Human Necessities | 27 | Expired |
| US5824668A | Formulation for administration of steroid compounds | Performing Operations; Transporting | 27 | Expired |
| US6017948A | Water-miscible pharmaceutical compositions | Human Necessities | 26 | Expired |
| US6174873A | Oral administration of adenosine analogs | Human Necessities | 24 | Expired |
| US6485514B1 | Local delivery of therapeutic agents | Human Necessities | 23 | Expired |
| US6538020B2 | Paclitaxel formulation | Performing Operations; Transporting | 22 | Expired |
| US7135464B2 | Method of administering decitabine | Human Necessities | 19 | Expired |
| US6509370B1 | Paclitaxel formulation | Performing Operations; Transporting | 17 | Expired |
| US5804568A | Pharmaceutical formulation | Performing Operations; Transporting | 17 | Expired |
| US6710195B2 | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions | Human Necessities | 15 | Expired |
| US7250416B2 | Azacytosine analogs and derivatives | Chemistry; Metallurgy | 14 | Expired |
| US6828346B2 | Methods for administration of paclitaxel | Performing Operations; Transporting | 14 | Expired |
| US7939546B2 | Quinoline derivatives for modulating DNA methylation | Human Necessities | 14 | Active |
| US6218374A | Pharmaceutical formulation | Performing Operations; Transporting | 13 | Expired |
| US6191119A | Combination therapy including 9-nitro-20(S)-camptothecin | Human Necessities | 13 | Expired |
| US6613753B2 | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation | Human Necessities | 12 | Expired |
| US6982253B2 | Liquid formulation of decitabine and use of the same | Human Necessities | 12 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.